Target | Name of compound | Mechanism | Effect | Ref. |
---|---|---|---|---|
RHO GTPases | ||||
 RAC | EHT 1864 | Lock in inactive state | Blocks migration and invasion of cancer cell | [141] |
 RAC/CDC42 | R-ketorolac | Targets RAC1 and CDC42 | Blocks migration and invasion of cancer cell | [142] |
 CDC42 | ML141 | Block nucleotide binding | Blocks migration and invasion of cancer cell | [143] |
 RHO/RAC/CDC42 | statins | Targeting HMG CoA reductase pathway to diminishing lipid modifications needed by Rho GTPases | Blocks proliferation and invasion of cancer cell | |
Interaction of RHO and effectors | ||||
 ROCK | ATS907 | Compete with ATP | In trial for glaucoma and ocular hypertension | [148] |
 | AR-12286 | Compete with ATP | In trial for glaucoma and ocular hypertension | [148] |
 | Y-27632 | Compete with ATP | Blocks proliferation, migration and invasion of cancer cell | [151] |
 | fasudil | Compete with ATP | Blocks proliferation, migration and invasion of cancer cell | |
 PAK | MBQ-167 | Blocks PAK phosphorylation | Blocks growth, migration and EMT of cancer cell | [155] |
 MRCK | BDP9066 | Compete with ATP | Blocks proliferation and invasion of cancer cell | [156] |
Interaction of RHO and RHOGEF | ||||
 RAC | NSC23766 | Blocks interaction of RAC1 with TIAM1 and Trio | Blocks migration and invasion of cancer cell | |
 | 1D-142 | Block GEF binding | Blocks growth and invasion of cancer cell | [161] |
 RAC/CDC42 | EHop-016 | Derivative of NSC23766 | Blocks migration and invasion of cancer cell | [160] |
 RHOA | Rhosin | Block GEF binding | Blocks migration and invasion of cancer cell | [162] |
 | DC-Rhoin | Binds to the surface of RHOA by Cys107 | Blocks migration and invasion of cancer cell | [140] |